XGenomes
XGenomes is building the sequencing technology of the future.
About
At XGenomes, we are building a technology comprising novel biochemistry, hardware and algorithms for sequencing DNA. Our product will be streamlined: there is zero library preparation; we sequence directly on unadulterated single molecules of DNA; DNA extraction will be integrated with sequencing; there is no bioinformatics bottleneck. The sequence we produce will be of unprecedented accuracy due to several layers of in-built redundancy including the sequencing both strands of the double-helix concurrently. The sequence we produce will be complete, encompassing: structural as well as single nucleotide variants; long-range haplotype phase; the repetitive "dark matter" of the genome. The cost of goods (consumables) of sequencing will be <$10, which will allow us to price our product at a level that will help grow the market while still achieving >90% margin. We will start by offering access as a service to high value customers, which be followed by a razor and blade model of selling instruments and consumables. XGenomes is a Y Combinator company (Winter 2019). YC-listed status: Active.
- Website
- xgenomes.com
- Location
- Boston, MA, USA; Cambridge, MA, USA
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- XGenomes — Next-generation multi-omic DNA sequencing platform using super-resolution imaging and AI to deliver low-cost, high-accuracy lifetime health monitoring without… · Hardware
Links
- Y Combinator profileycombinator